{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:59:32Z","timestamp":1774533572560,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.schres.2025.04.022","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T09:11:14Z","timestamp":1746263474000},"page":"82-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Psychosis associated with dementia: evaluation and management"],"prefix":"10.1016","volume":"281","author":[{"given":"Rajesh R.","family":"Tampi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip V.","family":"Jeste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.schres.2025.04.022_bb0010","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s10072-024-07477-w","article-title":"The efficacy and safety of lecanemab 10 mg\/kg biweekly compared to a placebo in patients with Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized controlled trials","volume":"45","author":"Abdelazim","year":"2024","journal-title":"Neurol Sci."},{"issue":"4","key":"10.1016\/j.schres.2025.04.022_bb0015","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3233\/JAD-215483","article-title":"Psychosis as a treatment target in dementia: a roadmap for designing interventions","volume":"88","author":"Ag\u00fcera-Ortiz","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0020","doi-asserted-by":"crossref","first-page":"1377191","DOI":"10.3389\/frdem.2024.1377191","article-title":"Psychosis detection in dementia: a systematic review of diagnostic test accuracy studies","author":"Atchison","year":"2024","journal-title":"Front Dement."},{"issue":"7","key":"10.1016\/j.schres.2025.04.022_bb0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00019442-200507000-00011","article-title":"Heritability of psychosis in Alzheimer disease","volume":"13","author":"Bacanu","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.022_bb0030","first-page":"1","article-title":"Electroconvulsive therapy in individuals with dementia\/major NCD presenting with behavioral symptoms: a systematic review","volume":"12","author":"Bachu","year":"2023","journal-title":"Int. Psychogeriatr."},{"issue":"1","key":"10.1016\/j.schres.2025.04.022_bb0035","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.AD19038BR3C","article-title":"Diagnosing dementia-related psychosis: using tools and communicating with patients and caregivers","volume":"82","author":"Ballard","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.04.022_bb0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4088\/JCP.v62n0110","article-title":"The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer\u2019s disease: persistence and new cases over 1 year of follow-up","volume":"62","author":"Ballard","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2025.04.022_bb0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.psy.44.5.388","article-title":"Delusions and hallucinations in Alzheimer\u2019s disease: review of the brain decade","volume":"44","author":"Bassiony","year":"2003","journal-title":"Psychosomatics"},{"issue":"10","key":"10.1016\/j.schres.2025.04.022_bb0050","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jamapsychiatry.2023.2225","article-title":"Prevalence of neuroradiological abnormalities in first-episode psychosis: a systematic review and meta-analysis","volume":"80","author":"Blackman","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2025.04.022_bb0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa2017015","article-title":"Muscarinic cholinergic receptor agonist and peripheral antagonist for schizophrenia","volume":"384","author":"Brannan","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0060","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/gps.2702","article-title":"Risk factors for the late-onset psychoses: a systematic review of cohort studies","volume":"27","author":"Brunelle","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2025.04.022_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/gps.6129","article-title":"Non-pharmacological interventions in the management of dementia-related psychosis: a systematic review and meta-analysis","volume":"39","author":"Burnand","year":"2024","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0070","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-191092","article-title":"The prevalence of dementia: a systematic review and meta-analysis","volume":"73","author":"Cao","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/cjn.2023.248","article-title":"A systematic review of the genetics and pathology of psychosis in frontotemporal dementia","volume":"51","author":"Chatterjee","year":"2024","journal-title":"Can. J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.schres.2025.04.022_bb0080","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.17219\/acem\/161159","article-title":"Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer\u2019s disease psychosis: a systematic review and meta-analysis","volume":"32","author":"Chen","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jagp.2017.10.011","article-title":"Psychosis and clinical outcomes in Alzheimer disease: a longitudinal study","volume":"26","author":"Connors","year":"2018","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2025.04.022_bb0090","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00019442-200307000-00003","article-title":"Psychotic symptoms in Alzheimer disease: evidence for subtypes","volume":"11","author":"Cook","year":"2003","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.04.022_bb0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-231363","article-title":"Psychosis in neurodegenerative dementias: a systematic comparative review","volume":"99","author":"Cressot","year":"2024","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.schres.2025.04.022_bb0100","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamaneurol.2023.1835","article-title":"Cholinesterase inhibitors for treatment of psychotic symptoms in Alzheimer disease and Parkinson disease: a meta-analysis","volume":"80","author":"d\u2019Angremont","year":"2023","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.schres.2025.04.022_bb0105","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/s41380-021-01152-8","article-title":"Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease","volume":"26","author":"DeMichele-Sweet","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2025.04.022_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S104161029700481X","article-title":"Use of the Columbia University Scale to assess psychopathology in Alzheimer\u2019s disease","volume":"9","author":"Devanand","year":"1997","journal-title":"Int. Psychogeriatr."},{"issue":"1","key":"10.1016\/j.schres.2025.04.022_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S1041610223000157","article-title":"Overview of late-onset psychoses","volume":"36","author":"Devanand","year":"2024","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.schres.2025.04.022_bb0120","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR\/American Psychiatric Association","year":"2022"},{"issue":"11","key":"10.1016\/j.schres.2025.04.022_bb0125","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jagp.2013.03.006","article-title":"Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum","volume":"22","author":"Donovan","year":"2014","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.022_bb0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neubiorev.2017.02.021","article-title":"Clinical and neurocognitive aspects of hallucinations in Alzheimer\u2019s disease","volume":"83","author":"El Haj","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.schres.2025.04.022_bb0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JAD-150606","article-title":"Lewy bodies, vascular risk factors, and subcortical arteriosclerotic leukoencephalopathy, but not Alzheimer pathology, are associated with development of psychosis in Alzheimer\u2019s disease","volume":"50","author":"Fischer","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.schres.2025.04.022_bb0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/gps.4291","article-title":"Gray matter atrophy in patients with mild cognitive impairment\/Alzheimer\u2019s disease over the course of developing delusions","volume":"31","author":"Fischer","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0150","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3233\/JAD-190828","article-title":"Revisiting criteria for psychosis in Alzheimer\u2019s disease and related dementias: toward better phenotypic classification and biomarker research","volume":"73","author":"Fischer","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.schres.2025.04.022_bb0155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/gps.5376","article-title":"Effect of biological treatments on psychotic symptoms in lewy body disease: a systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Ford","year":"2020","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.04.022_bb0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1751-7893.2008.00105.x","article-title":"Initial medical work-up of first-episode psychosis: a conceptual review","volume":"3","author":"Freudenreich","year":"2009","journal-title":"Early Interv. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2025.04.022_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5832","article-title":"Electroconvulsive therapy improves psychotic symptoms in patients with dementia with Lewy bodies","volume":"37","author":"Fukatsu","year":"2022","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2025.04.022_bb0170","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"issue":"2","key":"10.1016\/j.schres.2025.04.022_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cger.2019.11.010","article-title":"Managing behavioral and psychological symptoms of dementia","volume":"36","author":"Gerlach","year":"2020","journal-title":"Clin. Geriatr. Med."},{"issue":"19","key":"10.1016\/j.schres.2025.04.022_bb0180","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/jama.2012.36918","article-title":"Nonpharmacologic management of behavioral symptoms in dementia","volume":"308","author":"Gitlin","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000017228","article-title":"A 2-year follow-up of behavioural and psychological symptoms in Alzheimer\u2019s disease","volume":"11","author":"Haupt","year":"2000","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.schres.2025.04.022_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101568","article-title":"Pharmacological treatments for psychotic symptoms in dementia: a systematic review with pairwise and network meta-analysis","volume":"75","author":"Huang","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41582-021-00597-3","article-title":"Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities","volume":"18","author":"Ismail","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.schres.2025.04.022_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00019442-200002000-00004","article-title":"Psychosis of Alzheimer\u2019s disease and related dementias. Diagnostic criteria for a distinct syndrome","volume":"8","author":"Jeste","year":"2000","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2025.04.022_bb0215","doi-asserted-by":"crossref","DOI":"10.1177\/03000605241258473","article-title":"Is there evidence for using ketamine among individuals with dementia?","volume":"52","author":"Kapoor","year":"2024","journal-title":"J. Int. Med. Res."},{"issue":"10422","key":"10.1016\/j.schres.2025.04.022_bb0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(23)02190-6","article-title":"Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial","volume":"403","author":"Kaul","year":"2024","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.schres.2025.04.022_bb0225","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jamapsychiatry.2024.0785","article-title":"Efficacy and safety of xanomeline-trospium chloride in schizophrenia: a randomized clinical trial","volume":"81","author":"Kaul","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2025.04.022_bb0230","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.outlook.2017.06.006","article-title":"Determinants of behavioral and psychological symptoms of dementia: a scoping review of the evidence","volume":"65","author":"Kolanowski","year":"2017","journal-title":"Nurs. Outlook"},{"issue":"5","key":"10.1016\/j.schres.2025.04.022_bb0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.57.5.805","article-title":"Psychosis of Alzheimer\u2019s disease is associated with elevated muscarinic M2 binding in the cortex","volume":"57","author":"Lai","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.schres.2025.04.022_bb0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/S1041610214002580","article-title":"Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma?","volume":"27","author":"Landqvist Wald\u00f6","year":"2015","journal-title":"Int. Psychogeriatr."},{"issue":"2","key":"10.1016\/j.schres.2025.04.022_bb0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/psyg.12369","article-title":"Right hippocampus atrophy is independently associated with Alzheimer\u2019s disease with psychosis","volume":"19","author":"Lee","year":"2019","journal-title":"Psychogeriatrics"},{"issue":"11","key":"10.1016\/j.schres.2025.04.022_bb0250","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/gps.440","article-title":"An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer\u2019s disease","volume":"16","author":"Lyketsos","year":"2001","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2025.04.022_bb0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/01.WNL.0000129843.15756.A3","article-title":"Psychiatric comorbidities in patients with Parkinson disease and psychosis","volume":"63","author":"Marsh","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.schres.2025.04.022_bb0260","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/gps.4757","article-title":"Reduced parahippocampal volume and psychosis symptoms in Alzheimer\u2019s disease","volume":"33","author":"McLachlan","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2025.04.022_bb0265","first-page":"CD013304","article-title":"Antipsychotics for agitation and psychosis in people with Alzheimer\u2019s disease and vascular dementia","volume":"12","author":"M\u00fchlbauer","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.schres.2025.04.022_bb0270","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S1041610223000091","article-title":"Treatment of behavioral and psychological symptoms of dementia using transcranial magnetic stimulation: a systematic review","volume":"35","author":"Murphy","year":"2023","journal-title":"Int. Psychogeriatr."},{"issue":"12","key":"10.1016\/j.schres.2025.04.022_bb0275","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.neurobiolaging.2012.02.015","article-title":"\u03b2-Amyloid 42\/40 ratio and kalirin expression in Alzheimer disease with psychosis","volume":"33","author":"Murray","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.schres.2025.04.022_bb0280","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.biopsych.2013.08.020","article-title":"Psychosis in Alzheimer\u2019s disease","volume":"75","author":"Murray","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2025.04.022_bb0285","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S1041610213000094","article-title":"Content of delusional thoughts in Alzheimer\u2019s disease and assessment of content-specific brain dysfunctions with BEHAVE-AD-FW and SPECT","volume":"25","author":"Nakatsuka","year":"2013","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.schres.2025.04.022_bb0290","doi-asserted-by":"crossref","DOI":"10.1590\/1980-5764-dn-2022-0044","article-title":"The frequency of psychotic symptoms in types of dementia: a systematic review","volume":"17","author":"Pessoa","year":"2023","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.schres.2025.04.022_bb0295","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neurobiolaging.2020.01.001","article-title":"Psychosis-associated DNA methylomic variation in Alzheimer\u2019s disease cortex","volume":"89","author":"Pishva","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.schres.2025.04.022_bb0300","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1567205014666170829114346","article-title":"Association between psychosis phenotype and APOE genotype on the clinical profiles of Alzheimer\u2019s disease","volume":"15","author":"Qian","year":"2018","journal-title":"Curr. Alzheimer Res."},{"issue":"5","key":"10.1016\/j.schres.2025.04.022_bb0305","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jagp.2018.09.016","article-title":"Gray matter changes associated with the development of delusions in Alzheimer disease","volume":"27","author":"Qian","year":"2019","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2025.04.022_bb0310","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/01.wnl.0000341932.21961.f3","article-title":"Increased striatal dopamine (D2\/D3) receptor availability and delusions in Alzheimer disease","volume":"72","author":"Reeves","year":"2009","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.schres.2025.04.022_bb0315","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.neubiorev.2012.08.001","article-title":"Origins of delusions in Alzheimer\u2019s disease","volume":"36","author":"Reeves","year":"2012","journal-title":"Neurosci Biobehav Rev."},{"issue":"2","key":"10.1016\/j.schres.2025.04.022_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-014-0542-0","article-title":"Late-life psychosis: diagnosis and treatment","volume":"17","author":"Reinhardt","year":"2015","journal-title":"Curr Psychiatry Rep."},{"issue":"11","key":"10.1016\/j.schres.2025.04.022_bb0325","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1176\/appi.ajp.162.11.2022","article-title":"Epidemiology of and risk factors for psychosis of Alzheimer\u2019s disease: a review of 55 studies published from 1990 to 2003","volume":"162","author":"Ropacki","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0330","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S1041610221000260","article-title":"International Psychogeriatric Association (IPA) consensus for defining psychosis in major and mild neurocognitive disorders","volume":"34","author":"Sano","year":"2022","journal-title":"Int. Psychogeriatr."},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0335","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.bp.108.049619","article-title":"Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population","volume":"194","author":"Savva","year":"2009","journal-title":"Br J Psychiatry."},{"key":"10.1016\/j.schres.2025.04.022_bb0340","doi-asserted-by":"crossref","first-page":"109006","DOI":"10.1016\/j.neuropsychologia.2024.109006","article-title":"Neuroanatomical correlates and predictors of psychotic symptoms in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"204","author":"Scarfo","year":"2024","journal-title":"Neuropsychologia"},{"issue":"10","key":"10.1016\/j.schres.2025.04.022_bb0345","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.62.10.1601","article-title":"Delusions and hallucinations are associated with worse outcome in Alzheimer disease","volume":"62","author":"Scarmeas","year":"2005","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0350","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2025.04.022_bb0355","first-page":"CD008191","article-title":"Antidepressants for agitation and psychosis in dementia","author":"Seitz","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0360","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1017\/S0033291721002099","article-title":"Association between risk of dementia and very late-onset schizophrenia-like psychosis: a Swedish population-based cohort study","volume":"53","author":"Stafford","year":"2023","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.schres.2025.04.022_bb0365","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archneur.58.3.466","article-title":"Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis","volume":"58","author":"Sweet","year":"2001","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.schres.2025.04.022_bb0370","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.58.6.907","article-title":"Increased familial risk of the psychotic phenotype of Alzheimer disease","volume":"58","author":"Sweet","year":"2002","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.schres.2025.04.022_bb0375","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1176\/appi.ajp.20220508","article-title":"Dementia is more than memory loss: neuropsychiatric symptoms of dementia and their nonpharmacological and pharmacological management","volume":"179","author":"Tampi","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.022_bb0380","doi-asserted-by":"crossref","DOI":"10.1177\/2045125319882798","article-title":"Psychotic disorders in late life: a narrative review","volume":"9","author":"Tampi","year":"2019","journal-title":"Ther Adv Psychopharmacol."},{"key":"10.1016\/j.schres.2025.04.022_bb0385","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2021-7-3","article-title":"Aducanumab: evidence from clinical trial data and controversies","volume":"10","author":"Tampi","year":"2021","journal-title":"Drugs Context"},{"issue":"1","key":"10.1016\/j.schres.2025.04.022_bb0390","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12877-020-01607-7","article-title":"Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis","volume":"20","author":"Watt","year":"2020","journal-title":"BMC Geriatr."},{"issue":"5","key":"10.1016\/j.schres.2025.04.022_bb0395","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jamda.2024.03.007","article-title":"Guideline recommendations on behavioral and psychological symptoms of dementia: a systematic review","volume":"25","author":"Watt","year":"2024","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"7","key":"10.1016\/j.schres.2025.04.022_bb0400","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/alz.12901","article-title":"The worldwide costs of dementia in 2019","volume":"19","author":"Wimo","year":"2023","journal-title":"Alzheimer\u2019s & Dement."},{"issue":"5","key":"10.1016\/j.schres.2025.04.022_bb0405","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s12325-022-02075-8","article-title":"Comparative outcomes of commonly used off-label atypical antipsychotics in the treatment of dementia-related psychosis: a network meta-analysis","volume":"39","author":"Yunusa","year":"2022","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.schres.2025.04.022_bb0410","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/archneur.1991.00530180075020","article-title":"Neuropathologic and neurochemical correlates of psychosis in primary dementia","volume":"48","author":"Zubenko","year":"1991","journal-title":"Arch. Neurol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425001525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425001525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:03:26Z","timestamp":1774530206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996425001525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":78,"alternative-id":["S0920996425001525"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2025.04.022","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychosis associated with dementia: evaluation and management","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2025.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}